Skip to main content
Clinical Trials/NCT01877434
NCT01877434
Completed
Not Applicable

The TESS Reverse Shoulder Arthroplasty: Effect of Arm Lengthening and Early Scapular Notching at Three Years Follow-up

Sundsvall Hospital1 site in 1 country40 target enrollmentOctober 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Humerus Fracture
Sponsor
Sundsvall Hospital
Enrollment
40
Locations
1
Primary Endpoint
Patient reported outcome measurement Quick-DASH
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

Reverse total shoulder arthroplasty (RSA) is a accepted treatment for different shoulder diseases with improved functional outcome. This study has evaluated patients operated with reversed shoulder arthroplasty after 1,5-3 years postoperatively with patient reported outcome, clinical and radiological examination, complication and reoperations. The radiologic phenomenom and clinical impact of scapular notching (SN) and arm length difference has been evaluated.

Registry
clinicaltrials.gov
Start Date
October 2007
End Date
June 2013
Last Updated
12 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Sundsvall Hospital
Responsible Party
Principal Investigator
Principal Investigator

Lennart Bråbäck

Consultat medical doctor

Sundsvall Hospital

Eligibility Criteria

Inclusion Criteria

  • Operated with a reversed TESS total shoulder arthroplasty at Sundsvall hospital.

Exclusion Criteria

  • Do not give informed consent
  • Do not attend follow-up

Outcomes

Primary Outcomes

Patient reported outcome measurement Quick-DASH

Time Frame: 2007-2013

Secondary Outcomes

  • Range of movement(2007-2013)
  • Quality of life EQ5-D(2007-2013)

Study Sites (1)

Loading locations...

Similar Trials